Bullish indicating open at $55-$60, IPO prices at $37
In a challenging market environment, shares of Better Choice Company (BTTR) have reached a 52-week low, trading at $1.45. According to InvestingPro analysis, the company trades at just 0.29 times book value, suggesting potential undervaluation despite current market sentiment. The pet health and wellness company has faced significant headwinds over the past year, reflected in the stock’s performance with a stark 1-year change, plummeting by -72.44%. While investors have shown concern as the company navigates through uncertainty, its current ratio of 2.38 indicates strong short-term liquidity. The stock price struggles to find a foothold after hitting this new low, though the company maintains more cash than debt on its balance sheet. The decline to $1.45 marks a critical point for Better Choice Company as it seeks to regain investor confidence and reverse the downward trend. For deeper insights into BTTR’s valuation and 16 additional expert tips, visit InvestingPro.
In other recent news, Better Choice Company, Inc. has received court approval to move forward with its acquisition of SRx Health Solutions, Inc., a Canadian healthcare service provider. This transaction, approved by the Ontario Superior Court of Justice, is part of Better Choice’s strategic plan to expand its pet health and wellness offerings. The acquisition has also received overwhelming support from SRx’s shareholders, with about 93% voting in favor. Better Choice is set to hold a Special Meeting on March 21, 2025, to gather its own shareholders’ votes on the acquisition.
In other developments, Better Choice recently held its annual stockholder meeting, resulting in the election of five directors and the ratification of Marcum LLP as its independent auditor for the fiscal year ending December 31, 2024. The meeting saw a 60.70% turnout, with strong support for the board’s leadership and financial oversight practices. Additionally, a non-binding advisory vote on executive compensation was approved, indicating general agreement with the company’s compensation plan.
These recent developments highlight Better Choice’s focus on growth and expansion in the pet health sector, as well as its commitment to maintaining robust corporate governance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.